Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 7/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.34 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4459798 | 0.80 | AHR (0.50) | AHRCYP3A4HSP90AA1HSP90AB1TSHR | |
| SCHEMBL30034845 | 0.76 | CYP3A4 (0.67) | AHRCYP3A4HSP90AA1TSHRHPGD | |
| SCHEMBL2230314 | 0.76 | CYP3A4 (0.67) | AHRCYP3A4HSP90AA1TSHRHPGD | |
| SCHEMBL7604144 | 0.75 | HPGD (0.48) | AHRCYP3A4HSP90AA1HSP90AB1TSHR | |
| SCHEMBL28795908 | 0.75 | ALDH1A1 (0.54) | AHRCYP3A4HSP90AA1HSP90AB1TSHR | |
| SCHEMBL30444732 | 0.74 | AHR (0.48) | AHRCYP3A4HSP90AA1TSHRHPGD | |
| SCHEMBL4453591 | 0.74 | AHR (0.48) | AHRCYP3A4HSP90AA1TSHRHPGD | |
| SCHEMBL29422942 | 0.71 | AHR (0.68) | AHRCYP3A4HSP90AA1TSHRHPGD | |
| SCHEMBL404196 | 0.71 | AHR (0.68) | AHRCYP3A4HSP90AA1TSHRHPGD | |
| SCHEMBL29450677 | 0.70 | AHR (0.62) | AHRCYP3A4HSP90AA1TSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0128721-B1 | SILICA-MODIFIED CATALYST AND USE FOR SELECTIVE PRODUCTION OF PARA-DIALKYL SUBSTITUTED BENZENES | MOBIL OIL CORPORATION (US) | 1989-07-26 | — | — | EP | claimed |
| WO-2003059508-A1 | REFORMING CATALYST AND PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2003-07-24 | — | — | WO | disclosed |
| US-20030136708-A1 | Reforming catalyst and process | EXXONMOBIL RESEARCH & ENGINEERING CO. | 2003-07-24 | — | — | US | disclosed |
| US-6541408-B2 | Progressive temperature gradient stabilizes hydrorefining catalysts (metal-modified zeolite) to allow long duration of use and low by-product make | EXXONMOBIL OIL CORP. | 2003-04-01 | — | — | US | disclosed |
| US-20020091293-A1 | Zeolite catalysts having stabilized hydrogenation-dehydrogenation function | EXXONMOBIL OIL CORPORATION | 2002-07-11 | — | — | US | disclosed |
| US-6346498-B1 | PERMEATING METAL INTO MOLECULAR SIEVE; IN SITU SELECTIVATION WITH SILICON COMPOUND AND ROASTING; BY-PRODUCT INHIBITION | EXXONMOBIL OIL CORPORATION | 2002-02-12 | — | — | US | disclosed |
| US-6207871-B1 | CONVERTING A HYDROCARBON FEEDSTREAM COMPRISING ETHYLBENZENE AND META-XYLENE OVER MOLECULAR SIEVE CATALYST UNDER ETHYLBENZENE CONVERSION CONDITIONS, | MOBIL OIL CORPORATION | 2001-03-27 | — | — | US | disclosed |
| US-4532368-A | Passing mixture of phenol, ortho-alkylphenol, alkylating agent through zeolite catalyst, separating and recycling ortho-alkylphenols | ETHYL CORPORATION (US) | 1985-07-30 | — | — | US | disclosed |
| US-4444989-A | Methylation of toluene to para-xylene catalyzed by crystalline silica | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-04-24 | — | — | US | disclosed |
| US-4283306-A | CATALYTIC METHYLATION OF TOLUENE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091293-A1 | Zeolite catalysts having stabilized hydrogenation-dehydrogenation function | HDHD5, HSF1, HRH4 | AHR 10/4885CYP3A4 62/4885HSP90AA1 147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.